vasopharm GmbH - Company Review
vasopharm GmbH - Company ReviewSummary
vasopharm GmbH (vasopharm), formerly known as Vasopharm Biotech GmbH is a drug company that develops novel therapeutics for the treatment of cerebro and cardiovascular diseases. The company offers products such as VAS203, an allosteric NO synthase inhibitor that is used for traumatic brain injury and parenchyma. Its VAS2870 is used for the treatment of peripheral arterial occlusive diseases. vasopharm offers drug development in acute niche indications by targeting pathological nitric oxide production and signalling from discovery to a pivotal clinical trial. The company also provides treatment in the areas of acute cardiovascular and central nervous system diseases. vasopharm is headquartered in Wuerzburg, Germany.
This comprehensive company report of vasopharm GmbH provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.